1980 Nobel Prize in Physiology or Medicine — Benacerraf, Snell, and Dausset: MHC, the Self-Authentication System of Immunity

What You Will Learn

If the 1960 Prize (Burnet and Medawar) established the theory that immunity learns to recognize self during development, the 1980 Prize reveals the physical entity of that self-recognition — the Major Histocompatibility Complex (MHC). Understand how the mice from Jackson Laboratory, the resources from the Paris Transfusion Center, and the genetic analysis at Harvard combined to lay the foundation for today's understanding of organ transplantation, immunotherapy, and autoimmune diseases.

A Story Different from Common Sense — Cells Display Self-Certificates

The original article begins by stating the fundamental problem of immunity:

The immune system must be able to distinguish its own cells and the proteins it makes—self—from non-self in order to attack and defend against foreign invaders, antigens.

Benacerraf argued that the immune system’s immune response to antigens is genetically determined, and he named the genes involved immune response genes (Ir genes). He used inbred mouse strains and congenic mouse strains developed for organ transplantation studies to demonstrate that the antibody response to synthetic polypeptides is genetically determined.

The key unresolved question at this point: how does the immune system instantaneously determine whether each cell is self or non-self? The 1960 theory (Burnet) proposed the principle of "learning through experience," but how is this learned information physically stored and displayed?

The answer was the Major Histocompatibility Complex (MHC). Each cell displays MHC proteins on its surface, along with fragments of various proteins from within the cell (peptides). Immune sentinels (T cells) pass by and verify this display — if it is self MHC + self peptide, it passes; if it is different MHC, it attacks.

In the language of computer science, this system is a natural realization of a Public Key Infrastructure (PKI). Each cell displays a self-certificate (MHC) on its surface, and the sentinel verifies the certificate. If the certificate is missing or incorrect, the trust relationship fails → attack.

The Landscape of the Time — The New Cold War and a Major Shift in Korean Politics

1980 was a year marked by the start of the New Cold War and dramatic changes in Korean politics.

In Korean history, May 17 marked the expansion of martial law by the new military regime, followed by the Gwangju Democratization Movement on May 18 — hundreds died in the crackdown by the new military regime. A defining turning point in the late 20th-century Korean democratization movement. The establishment of the Chun Doo-hwan regime. A pivotal year of major change in Korea.

In world history, the Iran-Iraq War began in September — an eight-year, devastating war of attrition. In November, Ronald Reagan was elected president — a symbol of neoliberalism and Cold War hawkishness. In September, the Solidarity trade union was founded in Poland — the prelude to the collapse of Eastern European communism. On December 8, John Lennon was shot and killed in front of his apartment in New York — a symbolic ending to an era.

In this tumultuous year, the Nobel Committee recognized the physical mechanism of self/non-self recognition. At a time when the boundaries between self and non-self were being violently redrawn between nations and ideologies, the self/non-self recognition system within the body was revealed.

The Three Laureates — Harvard, Jackson Laboratory, Paris

Baruj Benacerraf (1920– ) was an American immunologist. The original article describes his remarkable life story:

Benacerraf was born in Caracas, Venezuela, and immigrated to the United States with his family in 1940, becoming a U.S. citizen in 1943. He graduated from the University of Virginia School of Medicine in 1945 and served in World War II as a physician with the U.S. Army in Europe. In 1948, he began his immunology research at the Columbia University Neurological Research Institute and served as a professor of pathology at New York University School of Medicine from 1956 to 1967. After serving as director of the Department of Immunological Research at the National Institute of Allergy and Infectious Diseases from 1968 to 1970, he served as a professor of comparative pathology at Harvard Medical School from 1970 to 1991 and as director of the Dana-Farber Cancer Institute from 1980 to 1991.

A trajectory from a Venezuelan-born Jewish immigrant to a Harvard professor + director of the Dana-Farber Cancer Institute. A representative example of the American immigration story of the late 20th century.

Benacerraf's key discovery was the Immune Response gene (Ir gene). He demonstrated that the immune response to specific antigens varies among individuals, and that this variation is determined by specific genes. Later, it was shown that these Ir genes are part of the MHC gene family.

George D. Snell (1903–1996) was an American geneticist. He received his Ph.D. from Harvard University in 1930 and then served as a senior researcher at the U.S. Jackson Laboratory from 1935 to 1969. The original article states:

The Jackson Laboratory is known as a leading research institute for studies on cancer and other diseases using mice.

The mice from the Jackson Laboratory were crucial. Snell developed several genetically homogeneous mouse strains (inbred mouse strains) and identified the major histocompatibility gene (H2 gene, the mouse version of MHC). He determined the genetic cause of why tissue transplantation is rejected between different strains.

The discovery of the H2 gene family is the mouse part of this prize. Later, it was shown that the corresponding system in humans is HLA.

Jean B. G. J. Dausset (1916– ) was a French immunologist. The original article states:

Dausset was born in Toulouse, France, and attended the University of Paris, but when World War II broke out in September 1939 and France was occupied by Nazi Germany a few months later, he joined the Free French Forces under de Gaulle and served in the transfusion service, where he became interested in transfusion reactions and antibody production in blood. After the war, in 1945, Dausset returned to medical school, graduated, and completed his residency, and from 1950 to 1963, he served as director of the French National Blood Transfusion Center, continuing his research.

His experience working in the transfusion service during the war led him to research immunology. The diverse blood samples he observed were a natural laboratory for studying how different people's blood reacts.

Dausset's key discovery was the HLA system (human leukocyte antigen) — various surface antigens of human white blood cells. It was later shown that this is the human MHC system. Dausset mapped the various polymorphisms of HLA by reacting blood cells and serums from different people in Paris.

Key Discoveries — The Three Roles of MHC

The discoveries of the three individuals together complete the picture of the MHC system.

MHC Class I (found on all cells):

• Expressed on the surface of almost all cells in the body.
• Displays peptide fragments derived from normal proteins within the cell.
• When a cell is infected with a virus, fragments of viral proteins are also displayed.
• Cytotoxic T cells (CD8+ T cells) monitor these MHC-peptide complexes. They kill the cell if they detect an abnormal peptide (e.g., a viral peptide).

MHC Class II (found on immune cells):

• Expressed on antigen-presenting cells (macrophages, dendritic cells, and B cells).
• Displays peptide fragments derived from foreign pathogens that have been engulfed.
• Helper T cells (CD4+ T cells) monitor this complex. Upon recognition, they activate the immune response.

MHC Polymorphism = Different Certificates for Each Individual:

• The MHC gene family is highly polymorphic (genetically diverse). Individuals within a species have different combinations of MHC genes.
• This diversity provides flexibility in responding to various pathogens.
• However, this diversity is the root cause of the difficulties in organ transplantation.

The original article states:

Furthermore, they showed that organ transplantation rejection is caused by the polymorphism of the MHC gene family, which made it possible to determine whether a donor and recipient are compatible by examining the HLA allotypes, which is a groundbreaking discovery that has drastically advanced organ transplantation and made it possible for it to be successful.

PKI Certificate System — CS Framework

Now, let's summarize the MHC system using the language of computer science.

Public Key Infrastructure (PKI) is a standard system for identity verification in the digital world. Each server or individual has a digital certificate, which they use to prove their identity during communication. Certificate authorities (CAs) issue and vouch for the trustworthiness of these certificates.

MHC is exactly this type of certificate system.

• Certificate = MHC protein: A standard format displayed on the surface of each cell.
• Certificate authority = the cell's genome: Each cell produces its own MHC sequence from its genes.
• Certificate content = payload peptides: Fragments derived from various proteins within the cell. In a normal state, these are self-protein fragments.
• Sentinel = T cells: These cells verify the certificates on each cell. If they detect an abnormality, they take action.

Strengths of this architecture:

• All cells use the same standard format to prove themselves — the same system is used regardless of the cell type.
• Sentinels can verify the certificate without opening up the cell — efficient surveillance.
• Infections can be detected immediately — when a cell is infected, viral peptides are displayed on its certificate.
• Different certificates for each individual — MHC polymorphism provides flexibility in responding to various pathogens.

Weaknesses: Organ and tissue transplantation between individuals is difficult because the certificates are different. This is like trying to communicate using certificates issued by different CAs, which leads to a failure of trust.

Software Example: In a microservices architecture, mTLS (mutual TLS) requires services to verify each other's certificates during communication. This is the same principle as T-cell surveillance of MHC. It is a fundamental component of the Zero Trust security model.

Viruses attempt to forge certificates: Various viruses have evolved mechanisms to interfere with MHC display. For example, HIV and several herpes viruses do this. This is an attempt to evade the immune system's certificate verification system.

Limitations of the analogy: Of course, the MHC system is much more probabilistic and dynamic than software PKI. The issuance of certificates is a combination of genetic and post-translational regulation, and there are various helper signals involved in the sentinel's judgment. However, the fundamental architecture of "standard certificate + sentinel verification" is exactly the same.

The Legacy That Continues Today

The impact of the MHC discovery continues in various fields today.

• Organ transplantation matching: HLA matching is a critical factor in the success of transplantation. Kidney, liver, heart, and hematopoietic stem cell transplants all require HLA matching. There are worldwide transplant registries.
• Immunosuppressive drugs: These drugs are used to suppress the rejection response after transplantation. Cyclosporine (1980s) and tacrolimus are standard treatments, and lifelong maintenance therapy is required.
• Susceptibility to autoimmune diseases: Certain HLA types are strongly associated with the susceptibility to specific autoimmune diseases (e.g., rheumatoid arthritis, ankylosing spondylitis).
• Immune checkpoint inhibitors: These drugs target MHC-related immune circuits to activate antitumor immunity. Nivolumab and pembrolizumab are examples. They were awarded the Nobel Prize in 2018.
• Personalized cancer immunotherapy: Predicting tumor antigens based on each patient's HLA type → designing personalized vaccines and CAR-T therapies.
• Susceptibility to viral infections: Certain HLA types influence the outcome of infections with HIV and COVID, among others.
• Paternity testing and forensic science: HLA genotypes were initially used for individual identification, but they have since been replaced by STRs.

Why It Matters

What the three laureates left behind is the establishment of "the cell surface certificate system as the physical entity of self-recognition."

The 1960 theory of "learning through experience" was made physical by the 1980 discovery of MHC certificates. Without this physical realization, we could not naturally understand "why immunity rejects transplanted organs" today. And without this understanding, there would be no tens of thousands of successful organ transplants worldwide each year.

Benacerraf, a Venezuelan-born Jewish immigrant, Snell, who created mouse strains at the Jackson Laboratory in the United States, and Dausset, a Frenchman whose life was changed by working in a blood transfusion unit during the war — the lives of three individuals from three continents converged to reveal the human body's self-recognition system. It is a representative example of international scientific collaboration in the late 20th century.

In the same year that the New Military Regime's crackdown in Gwangju violently redrew the boundaries between self and non-self in Korea, the physical system of self/non-self recognition within the body was revealed. This contrast gives this prize a unique historical significance.

1980 Benacerraf, Snell, and Dausset Summary: Benacerraf's discovery of the immune response gene (Ir gene), Snell's discovery of the mouse H2 gene family at the Jackson Laboratory, and Dausset's discovery of the human HLA system together established the MHC. The principle was established that the cell surface certificate system is the physical entity of self/non-self recognition. It is the theoretical root of today's HLA matching for organ transplantation, immunosuppressive drugs, understanding of autoimmune diseases, immune checkpoint inhibitors, and personalized cancer immunotherapy.

→ Previous: 1979 — Cormack and Hounsfield → Next: [1981 — Batch 8 waiting to be entered]